Figure 3. Kaplan–Meier curves indicate an increased cumulative risk for VTE depending on presence of nsVT (upper panel), of NT-proBNP serum levels >618 pg/ml (middle panel), and of FBN1 gene mutation in exons 24–32 (lower panel).